Essentials of Glycobiology Ajit Varki Lecture 35

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Chapter 19 Lecture Concepts of Genetics Tenth Edition Cancer and Regulation of the Cell Cycle.
Metastasis. Mechanisms of Invasion and Metastasis.
Etiology of cancer: Carcinogenic agents
The Cell Cycle and Cancer. Cell signaling: chemical communication between cells. Click on above to go to animation second chemical response inside the.
Platelets and Metastasis In Mice and in Humans, Platelets are Important Mediators of Metastatic process Gabriel Gasic, Tatiana Gasic, Carleton Stewart.
Interactions Between Cells and Their Environment
The Cell Cycle: CELLULAR REPRODUCTION What must happen before a cell can divide (reproduce)?
Cancer Genetics Is Cancer a Genetic Disease? Cancer is not a classic genetic disease, instead, Genetic background (set-up) has a definite role in cancer.
Cancer Cancer originates in dividing cells –Intestinal lining (colon) –Lung tissue –Breast tissue (glands/ducts) –Prostate (gland) –White blood cells.
Cancer Biology. 2 Outline 1.How do cancer cells differ from normal cells? Tumor progression Molecular basis for cancer.
34 Cancer.
Tissue Repair Dr. Raid Jastania. What is Repair? When does regeneration occur? When does fibrosis occur? What are the consequences of fibrosis?
Glycoconjugates Carbohydrates covalently linked to a protein or lipid act as informational carrier in: cell-cell recognition, cell-cell adhesion, cell.
Hallmarks of Cancer Six fundamental changes 1.Self sufficiency in growth factors 2.Insensitivity to growth-inhibitory signals 3.Evasion of apoptosis 4.Limitless.
1 Molecular Biology of Cancer Metastasis How the breakdowns of normal cell adhesions and stasis make cancers much more dangerous.
Essentials of Glycobiology May 5th., 2008 Ajit Varki Lecture 12 Chapter 13. Sequences Common to Different Glycan Classes Chapter 33. Galectins.
Chapter 19 Cancer and the Immune System Dr. Capers.
Genomics Lecture 7 By Ms. Shumaila Azam. Tumor Tumor – abnormal proliferation of cells that results from uncontrolled, abnormal cell division A tumor.
Cutured Cell Lines with Genetically Defined Disorders of Glycosylation Lecture 33 May 25, 2004 Jeff Esko.
Cancer immunology and immunotherapy. First an aside  Oncogenes and tumor suppressor genes.  Definitions anyone?  Oncogene –  Tumor suppressor gene.
Emily Hodgson Hallmarks of Cancer Immunology Drugs Metastasis.
CELL SIGNALING. THREE LEVELS OF CONTACT WITH ENVIRONMENT.
TUMOR IMMUNOLOGY Objectives
ESSENTIALS OF GLYCOBIOLOGY
Essentials of Glycobiology March 30th, 2004 Ajit Varki Lecture 1 Course Overview & General Introduction.
How Genes are Controlled Chapter 11. Human Cells…. All share the same genome What makes them different????
Essentials of Glycobiology Lecture 2 April 2, 2002 Ajit Varki General pathways for Biosynthesis Biological roles Evolutionary considerations.
Tumor genetics Minna Thullberg
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
Cancer What is cancer? How does it form? How can it be treated?
3.1.3.A Understanding Cancer What is Cancer.
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Cancer.
Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings.
Regulation of the Cell Cycle. Molecular Control System Normal growth, development and maintenance depend on the timing and rate of mitosis Cell-cycle.
Last lesson we looked at: What is the definition of a gene?
Cancer Uncontrolled cell growth. Cellular differentiation is the process by which a less specialized cell becomes a more specialized cell type. Occurs.
Human Biology Sylvia S. Mader Michael Windelspecht
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Essentials of Biology Sylvia S. Mader
Cell Division Brian Beaty AP Biology. What are the key roles of cell division? Reproduction Growth Repair.
1. Epithelial Mesenchymal Transition ( EMT ) 2 3.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Changes in the Eukaryotic Genome By: Sergio Aguilar.
10.3 Regulating the Cell Cycle
Lecture 12: Cancer: a cellular perspective Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular.
A.P. BiologyMr. Tesoro Dec. 10, 2015 Homework Reminder: Due Fri., Dec, 11, 2015 Read pages and Answer Ch. 9 Objectives (1,4,12,14)
Cell Biology Lec.5 Dr:Buthaina Al-Sabawi Date: Cell Biology Lec.5 Dr:Buthaina Al-Sabawi Date: The Cell Cycle The cell cycle, is the.
Host Defense Against Tumors (Tumor Immunity)
Dr. Hiba Wazeer Al Zou’bi
 The timing and rate of cell division is crucial to normal growth, development, and maintenance of multicellular organisms.
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
Cancer and the Immune System
HOST DEFENCE AGAINST TUMORS:
GENETIC BIOMARKERS.
Genes and Development CVHS Chapter 16.
The Genetic Basis of Cancer
Controls the Cell Cycle
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Activating Invasion and Metastasis
Activating Invasion and Metastasis
Cancer Genetics Genetics.
Msc clinical immunology
Genetics of Cancer.
Objectives: 1. Cancer and the cell cycle checkpoints, reqmts to advance oncogenes tumor suppressor genes 2. 6 Traits of cancerous cells 3. Facts on.
Presentation transcript:

Essentials of Glycobiology Ajit Varki Lecture 35 Changes in Glycosylation in Cancer

CLINICALLY RELEVANT CANCER INVOLVES A MULTISTEP PROCESS INHERITED GENOMIC DNA ABNORMALITIES DNA DAMAGE CAUSED BY EXTERNAL AGENTS IMMORTALIZATION OF GROWTH POTENTIAL ABNORMAL ONCOGENE EXPRESSION CAUSING INCREASED GROWTH LOSS OF TUMOR SUPPRESSOR GENES THAT NORMALLY CONTROL SUCH CELLS ACCUMULATION OF GENETIC ABNORMALITIES DEVELOPMENT OF GENETIC HETEROGENEITY, ALLLOWING TUMOR SPREAD (METASTASIS) METASTASIS IS NOW THE MAIN CAUSE OF DEATH IN HUMANS WITH CANCER

Clonal Expansion and Growth Angiogenesis Invasion of Basement Membrane Passage through Extracellullar Matrix Intravasation Tumor Cell interactions with Blood cells Adhesion to endothelium Invasion of basement membrane Extravasation Growth and Angiogenesis

Historical Background 1950s: Enhanced binding of certain plant lectins (e.g., wheat germ agglutinin) to animal tumor cells 1960s: In vitro transformation of cells frequently accompanied by increases in overall size of metabolically labelled glycopeptides. 1970-80s: Search for “magic bullet” monoclonal antibodies against cancer. Many “tumor-specific” antibodies directed against carbohydrate epitopes, especially on glycosphingolipids. 1980-90s: These epitopes are actually “oncofetal antigens” - also expressed in embryonic tissues, and in a few normal adult cell types

Historical Background (Continued) 1970-90s: Significant correlations between certain types of altered glycosylation and actual prognosis of tumor-bearing animals or patients. 1990s: Gene transfection experiments show that glycosylation changes may indeed be critical to aspects of tumor cell behavior. Late 1990s-2004: proof using mice with genetically altered glycosylation or glycan binding proteins. Late 1990s-2004: Diagnostic applications in humans, therapeutic applications in mice. Therapeutic applications in Humans are still few!

Altered glycosylation is an universal feature of tumor cells. Changes typically seen are highly selective and specific. Cancer Cells are genetically heterogenous and are constantly undergoing Micro-evolution (“Survival of the Fittest”). Thus, there is likely selection for highly specific changes seen in natural tumors.

General Ways In Which Glycosylation Can Be Altered in Malignant Cells Loss of expression of certain structures Excessive expression of certain structures Persistence of incomplete or truncated structures Accumulation of precursors Appearance of new structures. Note: Changes in early branch points in pathways can markedly decrease amount of one class of structures, while causing dominance of another. Only a limited subset of biosynthetic pathways are frequently correlated with malignant transformation and tumor progression

Changes in Core Structures and Core Proteins N-glycans: Altered Branching, especially over-expression of GlcNAc Transferase V (GNT-V) O-glycans: Dominance of truncated structures (T, Tn, sialyl-Tn). Excessive production and shedding of mucins Glycosphingolipids: Over-expression and shedding, especially in neuroectodermal tumors (melanoma, neuroblastoma etc.) Glycosaminoglycans: Altered expression, especially Hyaluronan (ligand for CD44). Altered expression of some Heparan Sulfate Proteoglycans GPI Anchors - losses in some leukemias.

Changes in Shared Outer Structures Increased outer chain alpha1-3(4) Fucosylation, generating Selectin ligands Increased Expression of Polylactosamines (Galectin Ligands) Altered Expression of ABO Blood Group Structures Increase in overall Sialic Acid content Enhanced expression of some Sialic acid linkages Alterations in Types of Sialic Acids

Major Glycan Classes in Animal Cells HYALURONAN GLYCOSAMINO- GLYCANS HEPARAN SULFATE CHONDROITIN SULFATE Major Glycan Classes in Animal Cells P S S S Ser-O- S S S S S -O-Ser NS NS Proteoglycan Ac N-LINKED CHAINS O-LINKED CHAIN GLYCOPHOSPHO- LIPID ANCHOR P S Etn P O N N Ser/Thr Asn Asn NH 2 GLYCOSPHINGOLIPID Glycoprotein INOSITOL Ac OUTSIDE P Sialic Acids INSIDE O-LINKED GlcNAc O Ser

Altered N-Linked Glycosylation in Tumor cells due to Overexpression of GNT-V

Altered N-Linked Glycosylation in Tumor cells due to Overexpression of GNT-V

Increased GlcNAc Transferase-V mediated 1-6 Branching of N-glycans Transcriptionally increased expression of GNT-V induced by viral and chemical carcinogenesis Cell lines with increased GNT-V expression show increased frequency of metastasis Spontaneous revertants for enzyme expression lose metastatic phenotype Clinical specimens of some tumors show increased staining with the lectin L-PHA, which preferentially recognizes 1-6 branched N-glycans

Increased GlcNAc Transferase-V mediated 1-6 Branching of N-glycans Transfection of GNT-V cDNA into cells causes: Visually obvious transformed phenotype Enhanced colony formation in agar Increased cell spreading Enhanced invasiveness through membranes Tumorigenic behavior in previously non-tumorigenic cells. By conventional criteria, these are characteristics of a true oncogene!

Suppression of Tumor growth and metastasis in (Mgat5) GlcNAcT-V-deficient mice Mgat5 (-/-) mice lack GlcNAcT-V products and appear fertile/normal Altered proliferation in lymphocytes and epithelium Mammary tumor growth and metastases induced by the polyomavirus middle T oncogene considerably decreased GNT-V stimulates membrane ruffling and Pl-3 kinase-protein kinase B activation - a positive feedback loop that amplifies oncogene signaling and tumor growth in vivo. Inhibitors of GNT-V could be useful in treatment by targeting dependency on focal adhesion and signaling for growth and metastasis

Increased 1-6 Branching of N-glycans in Cancer Precise mechanism(s) of biological outcomes unknown Increased polyllactosamines recognized by galectins? Increased outer chain polyfucosylation and sialyl Lewis X production -recognized by the selectins? General physical effect of branching itself? 1-6 branch has a "broken wing" conformation, perhaps directly associating the glycan with nearby peptide moeity? Altered functioning of glycosylated adhesion molecules like integrins and/or cadherins? Metabolic inhibition of N-glycan processing by swainsonine has the converse effects. Swainsonine now in clinical trials for patients with advanced cancer.

Major Glycan Classes in Animal Cells HYALURONAN GLYCOSAMINO- GLYCANS HEPARAN SULFATE CHONDROITIN SULFATE Major Glycan Classes in Animal Cells P S S S Ser-O- S S S S S -O-Ser NS NS Proteoglycan Ac N-LINKED CHAINS O-LINKED CHAIN GLYCOPHOSPHO- LIPID ANCHOR P S Etn P O N N Ser/Thr Asn Asn NH 2 GLYCOSPHINGOLIPID Glycoprotein INOSITOL Ac OUTSIDE P Sialic Acids INSIDE O-LINKED GlcNAc O Ser

Altered Expression/Shedding of Glycosphingolipids Many "tumor-specific" monoclonal antibodies raised against tumors recognize glycosphingolipids Some highly enriched in specific types of tumors e.g., Gb3/CD77 in Burkitt’s lymphoma and GD3 in melanomas Some tumors (particularly melanoma and neuroblastoma) synthesize very high levels of gangliosides Some, e.g., GD2 and GM2 not found at high levels in extraneural cells - targets for immunotherapy In vitro studies suggest that some gangliosides can affect growth control Large quantities of gangliosides "shed" by some tumors have strong immunosuppressive effects

Major Glycan Classes in Animal Cells HYALURONAN GLYCOSAMINO- GLYCANS HEPARAN SULFATE CHONDROITIN SULFATE Major Glycan Classes in Animal Cells P S S S Ser-O- S S S S S -O-Ser NS NS Proteoglycan Ac N-LINKED CHAINS O-LINKED CHAIN GLYCOPHOSPHO- LIPID ANCHOR P S Etn P O N N Ser/Thr Asn Asn NH 2 GLYCOSPHINGOLIPID Glycoprotein INOSITOL Ac OUTSIDE P Sialic Acids INSIDE O-LINKED GlcNAc O Ser

MUCINS IN NORMAL AND MALIGNANT EPITHELIUM Altered sugar chains CANCER Mucins NORMAL BASEMENT MEMBRANE

Mucins with Altered O-Glycosylation in Cancer Mucins are major carriers of altered glycosylation Mucin expression correlates with metastatic potential in some carcinomas Shed Mucins in body fluids have diagnostic value Mucins can block adhesion by cytolytic cells, e.g., NK cells. Mucins can show incomplete O-glycosylation

Truncated O-glycans on Mucins in Cancer Correlation between T and Tn expression, spontaneous antibodies directed against them, and prognosis The most extreme form of underglycosylation results in expression of "naked" mucin polypeptides Clinical trials underway to provoke/enhance these immune responses by injecting patients with peptide antigens, sometimes bearing multiple copies Tn of Sialyl-Tn Early results promising

Major Glycan Classes in Animal Cells HYALURONAN GLYCOSAMINO- GLYCANS HEPARAN SULFATE CHONDROITIN SULFATE Major Glycan Classes in Animal Cells P S S S Ser-O- S S S S S -O-Ser NS NS Proteoglycan Ac N-LINKED CHAINS O-LINKED CHAIN GLYCOPHOSPHO- LIPID ANCHOR P S Etn P O N N Ser/Thr Asn Asn NH 2 GLYCOSPHINGOLIPID Glycoprotein INOSITOL Ac OUTSIDE P Sialic Acids INSIDE O-LINKED GlcNAc O Ser

Hyaluronan (HA) in Cancer Epithelial tumors surrounded by stroma enriched in HA. Corresponding normal epithelia give very low signal for HA Extent of stromal HA accumulation -a strong, independent, negative predictor of survival in many cancers Three major molecular characteristics of HA contribute to normal and tumor cell behavior Unique hydrodynamic properties Interactions with HA-binding “hyaladherins” in the assembly of pericellular and extracellular matrices. Effects on cell signaling and behavior.

Hyaluronan in Cancer Extracellular matrix surrounding proliferating and migrating cells in embryonic development, regeneration, healing, cancer and vascular disease is highly enriched in HA Simple interpretation: HA creates fluid, malleable matrix in which cells can change shape or migrate. HA synthase activity peaks at mitosis. Inhibition of HA synthesis causes cell cycle arrest, just before cell rounding HA interaction with hyaladherins (versican, aggrecan, TSG-6 etc.) in matrix creates microenvironment that supports and promotes dividing and migrating cells. HA interacts with cells by: binding to surface receptors, (e.g., CD44,RHAMM) giving signal transduction and cytoskeletal rearrangements being deposited in cytoplasm? Several intracellular hyaladherins, e.g. Cdc37, IHABP4, an intracellular form of RHAMM are known

Hyaluronan in Cancer - evidence in animal models HA overexpression promotes growth of fibrosarcoma and prostate carcinoma and mammary carcinoma metastasis. Overexpression of soluble soluble CD44, RHAMM, or other hyaladherins displaces endogenous HA from its receptors, and inhibits tumor growth and metastasis. Soluble hyaladherins cause loss of HA-induced clustering of plasma membrane CD44, which normally docks gelatinase B (MMP-9) on surface of malignant cells - which promotes tumor cell invasiveness and angiogenesis Soluble CD44 induces G1 arrest or apoptosis in tumor cells and inhibition of MMP-mediated invasion.

Hyaluronan in Cancer - evidence in animal models HA oligosaccharides inhibit in vivo tumor growth, presumably by competing for endogenous interactions. HA oligomers also induce G1 arrest or apoptosis in tumor cells - inhibition of the PI 3-kinase-Akt survival pathway? Some tumor cells have increased hyaluronidase and ability to internalize and degrade HA. Penetration of HA-rich stroma or production of angiogenic HA breakdown products may promote progression. HA-RHAMM interactions involved in Ras and signal-regulated kinase signaling pathways. Suppression inhibits cell locomotion and proliferation in vitro and inhibition of tumor growth in vivo Overexpression of RHAMM leads to enhanced tumor growth and metastasis

Major Glycan Classes in Animal Cells HYALURONAN GLYCOSAMINO- GLYCANS HEPARAN SULFATE CHONDROITIN SULFATE Major Glycan Classes in Animal Cells P S S S Ser-O- S S S S S -O-Ser NS NS Proteoglycan Ac N-LINKED CHAINS O-LINKED CHAIN GLYCOPHOSPHO- LIPID ANCHOR P S Etn P O N N Ser/Thr Asn Asn NH 2 GLYCOSPHINGOLIPID Glycoprotein INOSITOL Ac OUTSIDE P Sialic Acids INSIDE O-LINKED GlcNAc O Ser

Sulfated Glycosaminoglycans in Cancer Tumor metastasis hardly ever occurs in cartilage, which is very rich in Chondroitin Sulfate - mechanisms unknown (apparent basis for the huge market in shark cartilage!) Matrix HS-GAGs act a barrier to invasion and metastasis, HS-GAGS on tumors could play a facilitatory role, by recruiting and/or stabilize growth factors or matrix metalloproteases, or promoting angiogenesis. CHO mutants with decreased HS-GAG production do not form tumors in nude mice. Mechanism may involve change in humoral immune response and/or change of a “salvage” polyamine transport system

Multiple Hereditary Exostosis Autosomal dominant trait Bony outgrowths (exostoses) usually located next to epiphyseal growth plate Skeletal deformities such as shortened or curved limbs, reduced stature Pain caused by muscle and nerve compression 0.5 - 2% predilection for progression to malignant chondrosarcoma, i.e., a “tumor-suppressor gene”

Multiple Hereditary Exostosis Patients with Multiple Hereditary Exostosis have mutations in EXT1 and EXT2 The heparan sulfate copolymerase consists of an heterooligomer of EXT1 and EXT2 GlcA and GlcNAc transferase active sites of the copolymerase reside in separate subdomains Several mutations in EXT1 and EXT2 can result in deficient heparan sulfate synthesis Heterozygous state produce hereditary exostosis Note: homozygous null state is lethal and mice, and not seen in living humans

Common Outer Chains Shared by Different Classes of Glycans = Sialic acid S N-LINKED CHAIN O N Ser/Thr Asn O-LINKED CHAIN Secreted Protein GLYCOSPHINGOLIPID S O N Ser/Thr Membrane Protein Asn OUTSIDE CELL MEMBRANE INSIDE

Prognostic significance of Sialyl Lewisx expression in patients with colon adenocarcinoma from Nakamori et.al, 1997 Siaa2-3Galb1-4GlcNAcb1- 3 1 a Fuc SLex expression also associated with poor prognosis in carcinomas of Breast, Lung, Pancreas, Bladder, Prostate, Biliary tree and Ovary DO SELECTINS PLAY IN ROLE IN ADENOCARCINOMA PROGRESSION?

Interactions between Carcinoma Mucins and Selectins Tissue Factor? Resting platelet Thrombin APt Leukocyte Activated Carcinoma L-selectin P-selectin platelet cell L P APt Leukocyte Soluble Mucin Membrane- bound Mucin E E-selectin Activated Endothelium Selectin Binding sites

Effects of Selectin Deficiencies on the Metastatic Progression of GFP-expressing MC-38 Mouse Adenocarcinoma in Syngeneic Mice P- and L-selectin deficiency are additive P-selectin deficiency works by preventing tumor cell interactions with blood platelets Mechanism(s) of metastasis reduction by L-selectin deficiency unknown E-selectin may also play a role

Perioperative Heparin Therapy Reduces Late Deaths from Metastatic Cancer Control Heparin (Others) Control (Others) Heparin (Cancer) Control (Cancer) Kakkar et al. Int.J.Oncol. 6:885,1995. A retrospective analysis of 1250 patients randomized for peri-operative heparin prophylaxis against venous thrombosis

Diverse Effects of Heparin in Cancer Blockade of P- and L-selectin Inhibition of the Clotting Cascade Interactions with Integrins Binding up of Growth factors Inhibition of Angiogenesis Inhibition of Heparanases Alterations of Protease actions Lots of clinical heparin (standardized for anticoagulation) may vary in the other actions Very few studies show a detrimental consequence of heparin in murine or human cancer

Galectins and Polyllactosamines in Cancer Increased expression of galectins (especially galectin-3) associated with tumor progression and metastasis Mechanism may involve interactions of galectins with polylactosamines on matrix proteins like laminin. Polylactosamines also expressed on cancer mucins and enriched on 1-6 branched glycans of tumor N-glycans Thus, galectin-polyllactosamine interactions could mediate homotypic adhesion of carcinoma cells Remains to be shown exactly how interactions of galectins & polyllactosamine alter cancer biology

Altered Expression ABO Blood Group Structures in Cancer Loss of normal AB blood group expression (accompanied by increased expression of H and Le y) associated with a poorer prognosis of carcinomas in several studies Reason for this correlation remains unknown Rarely, a tumor may present an “illegal” blood group (i.e. expression of B blood group in an A-positive patient) Ggenetic basis for such a change remains unexplained Tumor regression noted in a few such cases, presumably mediated by naturally occurring endogenous antibodies

Changes in the Amount, Linkage and Type of Sialic Acids Most tumor cells show overall increase in cell surface sialic acid content Greatest increase in metastatic tumors Increased Sia shown to reduce attachment of tumor cells to collagen type IV and fibronectin Increase in Sia2-6Galb1-4GlcNAc (ST6Gal-I product) and Sia2-6GalNAc  -O-Ser/Thr (Sialyl-Tn) in some tumors. Associated with poor prognosis. 9-O-acetylated ganglioside GD3 in melanomas from a wide variety of species, ranging from humans to fish Loss of sialic acid 9-O-acetylation in Colon carcinomas Biological significance of most of these unknown

N-glycolylneuraminic Acid (Neu5Gc) in Human Tumors Neu5Gc differs from Neu5Ac by single oxygen atom, which is added by a specific hydroxylase Humans are deficient in Hydroxylase and in Neu5Gc Humans mount immune response to Neu5Gc in infused animal serum Reports of aberrant Neu5Gc expression in human tumors Is there an alternate pathway for synthesis of Neu5Gc? Or does it come from dietary sources? Neu5Gc accumulation may explain why some patients with cancer spontaneously develop "Hanganutziu-Deicher" “serum-sickness-like” antibodies that are directed against Neu5Gc-containing gangliosides.